Badi El Osta
Medical Oncology · Decatur, GANPI 1396876835
Payments from drug & device makers
What this record shows
This record is dominated by education: $61 of the $61 with a category attached, or 100.0%. Merck accounts for 74.6% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for medical oncology clinicians in GA, where the typical reported total is $5,509.
Across 3 payments — averaging $20.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$46
- Pfizer$16
Across 12 payments — averaging $293,230 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$3.5M
- Novartis$15K
What the payments were for
- Education$61100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$61 in reported general payments places this provider in the 5th percentile of 68 medical oncology providers in Georgia.
Other medical oncology in Decatur
- Hagop YoussoufianDecatur$78K
- Samir KhleifAugusta$337K
- Nabil SabaAtlanta$225K
- Sreekanth ReddyVidalia$116K
- Suresh RamalingamAtlanta$75K
- Jonathan KaufmanAtlanta$73K
- Ragini KudchadkarAtlanta$69K
- Nisha JosephAtlanta$50K
- Eyal MeiriAtlanta$39K
- Bradley SumrallMacon$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.